Xspray Pharma Ab Stock Filter Stocks by Fundamentals
XSPRAY Stock | SEK 40.45 0.20 0.50% |
XSpray Pharma AB fundamentals help investors to digest information that contributes to XSpray Pharma's financial success or failures. It also enables traders to predict the movement of XSpray Stock. The fundamental analysis module provides a way to measure XSpray Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to XSpray Pharma stock.
XSpray |
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
XSpray Fundamentals
Return On Equity | -0.24 | |||
Return On Asset | -0.14 | |||
Operating Margin | (116.51) % | |||
Current Valuation | 1.16 B | |||
Shares Outstanding | 22.68 M | |||
Shares Owned By Insiders | 47.42 % | |||
Shares Owned By Institutions | 27.60 % | |||
Price To Book | 2.35 X | |||
Price To Sales | 1,206 X | |||
Gross Profit | 656 K | |||
EBITDA | (87.82 M) | |||
Net Income | (96.7 M) | |||
Cash And Equivalents | 192.85 M | |||
Cash Per Share | 12.79 X | |||
Total Debt | 1.19 M | |||
Debt To Equity | 2.80 % | |||
Current Ratio | 26.45 X | |||
Book Value Per Share | 24.95 X | |||
Cash Flow From Operations | (51.61 M) | |||
Earnings Per Share | (5.18) X | |||
Target Price | 135.0 | |||
Number Of Employees | 26 | |||
Beta | 0.97 | |||
Market Capitalization | 1.45 B | |||
Total Asset | 622.9 M | |||
Net Asset | 622.9 M |
About XSpray Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze XSpray Pharma AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XSpray Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XSpray Pharma AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XSpray Pharma AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the XSpray Pharma AB information on this page should be used as a complementary analysis to other XSpray Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for XSpray Stock analysis
When running XSpray Pharma's price analysis, check to measure XSpray Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XSpray Pharma is operating at the current time. Most of XSpray Pharma's value examination focuses on studying past and present price action to predict the probability of XSpray Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XSpray Pharma's price. Additionally, you may evaluate how the addition of XSpray Pharma to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |